Lumos Diagnostics Holdings Limited

ASX (AUD): Lumos Diagnostics Holdings Limited (LDX)

Last Price

0.071

Today's Change

+0.042 (144.82%)

Day's Change

0.067 - 0.08

Trading Volume

66,043,289

Overview

Market Cap

53 Million

Shares Outstanding

748 Million

Avg Volume

985,746

Avg Price (50 Days)

0.03

Avg Price (200 Days)

0.03

PE Ratio

-7.10

EPS

-0.01

Earnings Announcement

26-Aug-2025

Previous Close

0.03

Open

0.08

Day's Range

0.067 - 0.08

Year Range

0.019 - 0.08

Trading Volume

66,043,289

Price Change Highlight

1 Day Change

144.83%

5 Day Change

144.83%

1 Month Change

153.57%

3 Month Change

222.73%

6 Month Change

77.50%

Ytd Change

86.84%

1 Year Change

75.97%

3 Year Change

28.25%

5 Year Change

-93.72%

10 Year Change

-93.72%

Max Change

-93.72%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment